JNJ - Evolus Alvotech gain as Barclays raises to Ovrweight
2024-01-29 13:28:50 ET
More on Alvotech, Evolus, etc.
- Evolus: Negative Earnings Continue Despite Sustained Top-Line Growth
- Alvotech: Biosimilars Portfolio Opportunity Is High Risk
- Alvotech (ALVO) Q3 2023 Earnings Call Transcript
- Alvotech stock jumps 15% on Stelara, Humira biosimilars updates (update)
- Evolus shares rise on upbeat 2024 revenue outlook